Form 4: Organon Executive Reports RSU Vesting, Share Transactions

Organon & Co.'s General Counsel, Kirke Weaver, reported the vesting of Restricted Stock Units and subsequent share transactions.

Summary

• Kirke Weaver, General Counsel & Corporate Secretary of Organon & Co., reported transactions on March 29, 2026.
• Acquired 7,757 shares of Organon common stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.
• Disposed of 2,210 shares of common stock at $5.84 per share, likely for tax withholding related to the RSU vesting.
• Beneficial ownership of common stock after these transactions is 79,401.163 shares.
• The disposition price of $5.84 was the closing market price on Friday, March 27, 2026, as required by the RSU plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents routine executive compensation and continued insider ownership, without indicating any significant strategic shifts or financial distress.

Positives

• An insider (General Counsel) continues to hold a significant number of shares (79,401.163), indicating alignment with shareholder interests.
• The vesting of RSUs is a standard component of executive compensation, reflecting continued employment and performance incentives.

Negatives

• A portion of shares (2,210) was disposed of, reducing the direct beneficial ownership, although this is a common practice for tax withholding upon RSU vesting.

Future Outlook

This Form 4 filing is a transactional report and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, reflecting compensation events like RSU vesting. These transactions are common across industries for executive incentive plans and do not typically signal a change in company strategy or performance.

Comparison to Industry Standards

• This type of RSU vesting and subsequent tax-related share disposition is a standard practice for executive compensation across publicly traded companies, aligning executive incentives with long-term shareholder value. No specific comparable companies or projects are detailed in this transactional filing.

Stakeholder Impact

• Shareholders: Minor dilution from RSU issuance, but also alignment of executive interests through continued share ownership.
• Employees: Reflects standard executive compensation practices for executives.

Next Steps

• The final installment of RSUs for Kirke Weaver is scheduled to vest on March 29, 2027.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of Restricted Stock Units and subsequent tax-related share disposition. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The continued significant beneficial ownership by a key executive is a neutral to slightly positive signal, but insufficient to alter a 'hold' stance based solely on this filing.

Keywords

Organon & Co., OGN, Form 4, Insider Transaction, Restricted Stock Units, RSU, Beneficial Ownership, Executive Compensation, Kirke Weaver